T1	Pharmacological_substance 16 25	linezolid
N1000 	Reference T1 MeSH:D000069349	linezolid
T2	Disorder 38 52	critically ill
T3	Pharmacological_substance 83 92	linezolid
N1001 	Reference T3 MeSH:D000069349	linezolid
T4	Pharmacological_substance 97 105	rifampin
N1002 	Reference T4 MeSH:D012293	rifampin
T5	Disorder 115 139	gram-positive infections
N1 	Reference T5 UMLS:C3714514	gram-positive infections
T6	Pharmacological_substance 234 243	linezolid
N1003 	Reference T6 MeSH:D000069349	linezolid
T7	Pharmacological_substance 249 257	rifampin
N1004 	Reference T7 MeSH:D012293	rifampin
T8	Disorder 466 551	disseminated community-acquired methicillin-resistant Staphylococcus aureus infection
T9	Pharmacological_substance 604 613	linezolid
N1005 	Reference T9 MeSH:D000069349	linezolid
T10	Pharmacological_substance 618 626	rifampin
N1006 	Reference T10 MeSH:D012293	rifampin
T11	Disorder 767 781	critically ill
T12	Pharmacological_substance 812 821	linezolid
N1007 	Reference T12 MeSH:D000069349	linezolid
T13	Pharmacological_substance 826 834	rifampin
N1008 	Reference T13 MeSH:D012293	rifampin
T14	Pharmacological_substance 660 669	linezolid
N1009 	Reference T14 MeSH:D000069349	linezolid
T17	Combination 71 82	concomitant
T18	Subject 53 60	patient
T22	Pharmacological_substance 204 217	antimicrobial
N1010 	Reference T22 MeSH:D000900	antimicrobial
N1011 	Reference T22 MeSH:D000890	antimicrobial
T23	Combination 192 203	Combination
T25	Disorder 278 287	bacterial
N2 	Reference T25 UMLS:C4038931	bacterial
T26	Disorder 315 325	resistance
T27	Speculation_cue 330 335	often
T30	Subject 451 460	a patient
T31	Speculation_cue 570 578	possible
T33	Combination 800 811	concomitant
T35	Subject 765 766;782 789	a patient
T36	Speculation_cue 736 744	possible
